Galderma
Galderma is a global dermatology company founded in 1981 as a joint venture between Nestlé and L’Oréal. It later operated as Nestlé Skin Health before being carved out and launched as a standalone company in 2019, and it was listed on the SIX Swiss Exchange in March 2024. The company develops and markets science-based solutions across injectable aesthetics, dermatological skincare, and therapeutic dermatology, addressing conditions such as acne, rosacea, psoriasis and pigmentary disorders, skin cancer, and skin aging. Its products are sold in about 80 countries through a worldwide network of affiliates and distributors, supported by thousands of employees. The brand portfolio includes dermatology and aesthetic products such as Differin, Cetaphil, Restylane, Emervel, Mirvaso, Loceryl, and Metvix, among others.
3 past transactions
Alastin Skincare
Acquisition in 2021
Alastin Skincare is a California-based company that specializes in developing innovative and clinically-validated skincare products aimed at enhancing and maintaining healthy skin. Founded in 2015 and located in Carlsbad, the company focuses on creating physician-dispensed products that utilize advanced technology and a proprietary blend of peptides to support the skin's natural regeneration processes. Their offerings include solutions for both ablative and non-ablative rejuvenating procedures, ensuring that dermatologists and plastic surgeons can effectively assist their patients in correcting, protecting, and preserving their skin health. Alastin Skincare emphasizes safety and effectiveness through rigorous clinical testing of its products.
Q-Med
Acquisition in 2011
Q-Med is a medical device company that specializes in the development, manufacturing, marketing, and sale of medical implants. The company is known for its patented technology, NASHA™, which enables the production of stabilized non-animal hyaluronic acid. Q-Med's product portfolio includes implants utilized in various medical fields, such as aesthetics, uro-gynecology, cell therapy, and encapsulation. By focusing on innovative solutions, Q-Med aims to address specific medical needs while enhancing patient outcomes.
CollaGenex Pharmaceuticals
Acquisition in 2008
CollaGenex Pharmaceuticals is a pharmaceutical company based in Newtown, Pennsylvania, focused on developing and marketing proprietary therapies for the dermatology market.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.